Lymphoproliferative Disorders Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy

VINCENZO LISO,* STEFANO MOLICA,# SILVANA CAPALBO,* ENRICO POGLIANI,@ COSIMA BATTISTA,* GIORGIO BROCCIA,^ MARCO MONTILLO,§ ANTONIO CUNEO,° PIETRO LEONI,** GIORGINA SPECCHIA,* GIANLUIGI CASTOLDI° *Institute of Hematology, University of Bari; °Section of Hematology, Department of Biomedical Sciences, University of Ferrara; #Division of Hematology and Clinical Oncology, “A. Pugliese” Hospital, Catanzaro; @Division of Hematology “San Gerardo dei Tintori” New Hospital, Monza; ^Division of Hematology, “A. Businco” Hospital, Cagliari; §Department of Hematology, Niguarda “Ca’ Granda” Hospital, Milan; Institute of Hematology, University of Ancona, Italy Correspondence: Vincenzo Liso, MD, Hematology, University of Bari, Policlinico, piazza G. Cesare 11, 70124 Bari, Italy. Phone: international +39.080.5478711. Fax: international +39.080. 5428978. E-mail: [email protected]